Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,616.50
Bid: 1,618.00
Ask: 1,618.50
Change: 4.50 (0.28%)
Spread: 0.50 (0.031%)
Open: 1,607.50
High: 1,620.00
Low: 1,594.00
Prev. Close: 1,612.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks end flat between Asia worries, British re-opening cheer

Mon, 17th May 2021 09:43

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Asia restrictions, China data weigh

* Kinnevik jumps to top of STOXX 600

* Spain's Telefonica gains as it seeks buyers for delivery
arm

* Sanofi, GSK gain as COVID-19 vaccine shows immune response
(Updates with market close)

By Shashank Nayar and Sruthi Shankar

May 17 (Reuters) - European stocks ended flat on Monday as
underwhelming Chinese data and caution over the spread of a
COVID-19 variant outweighed optimism on the reopening of the
British economy, while Sweden's Kinnevik surged and was the top
performer.

The pan-European STOXX 600 index ended flat with
travel and leisure stocks being the top losers, down
2.3%, while telecommunication stocks jumped the most,
led by gains in Spanish telecom firm Telefonica

Dampening sentiment was data showing that China's factories
slowed their output growth in April and retail sales
significantly missed expectations as officials warned of new
problems affecting the economic recovery.

Meanwhile, fresh restrictions across Asia following a new
wave of COVID-19 cases and concerns over the spread of a
fast-spreading coronavirus variant first identified in India
overshadowed optimism on UK's economic reopening.

"Airlines are on the back foot once again today, with
optimism over the reopening of international travel proving
short-lived given concerns over the growth of the Indian COVID
variant," said Joshua Mahony, senior market analyst at IG.

"Unfortunately, the risks posed by this latest strain also
raise questions around those same businesses that have just
found reprieve from lockdown restrictions, with pub and
restaurant chains all on the back foot despite the resumption of
indoor dining," added Mahony.

Britain's domestically focused mid-cap index dropped
0.6%, with restaurant and pub operator SSP Group and
airlines Easyjet and Wizz Air Holdings being
the top drags.

Irish airline Ryanair fell 2.8% after reporting a
record annual after-tax loss, as it said there were signs the
recovery had begun.

European stocks have performed well so far and surged to
all-time highs this month, with the STOXX 600 up nearly 11% so
far this year as economic recovery prospects and strong earnings
drew buyers of equities.

The European Union has agreed to a partial truce with the
United States in a dispute over metal tariffs imposed by former
President Donald Trump and to start discussions on global
overcapacity and China's "trade-distorting" policies.

Mining stocks gained 0.9%.

In corporate news, Sweden's Kinnevik jumped 8.5%
to the top of the STOXX 600 index after the company transferred
its stake in online fashion retailer Zalando to
shareholders.

Spanish telecoms group Telefonica gained 3.5% as it
is seeking buyers for its logistics and express-delivery unit
Zeleris, a source familiar with the offer said on Monday, amid a
months-long boom in the business as COVID-19 pushes people to
shop online.

Drugmakers Sanofi and GlaxoSmithKline
jumped 1% and 0.7% respectively after their experimental
COVID-19 vaccine showed a robust immune response in early-stage
clinical trial results, enabling them to move to a late-stage
study.
(Reporting by Sruthi Shankar and Shashank Nayar in Bengaluru;
Editing by Subhranshu Sahu and Dan Grebler)

More News
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.